Literature DB >> 20624523

Hereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation.

Karen E Matsukuma1, Franklin M Mullins, Lisa Dietz, James L Zehnder, James M Ford, Nicolette M Chun, Iris Schrijver.   

Abstract

Our patient was a 52-year-old man who was diagnosed with signet ring cell gastric adenocarcinoma. An extensive family history of gastric cancer raised suspicion for hereditary diffuse gastric cancer. Sequencing of the patient's CDH1 gene revealed a novel point mutation in a strictly conserved splice site within intron 6, c.833-2 A > G. This mutation was predicted to result in loss of function due to defective RNA splicing. To characterize the pathogenic mechanism of this mutation, we amplified the patient's CDH1 gene products by reverse transcriptase polymerase chain reaction. Primers flanking the region of the mutation detected 3 distinct transcripts. In addition to the wild-type product, a larger product consistent with activation of a cryptic splice site within intron 6 and a smaller product shown to result from exon 7 skipping were detected. In summary, we have identified a novel CDH1 mutation in a large hereditary diffuse gastric cancer kindred and identified its pathogenic mechanism. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624523     DOI: 10.1016/j.humpath.2010.01.022

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

Review 1.  Hereditary diffuse gastric cancer: a family diagnosis and treatment.

Authors:  Adedayo A Onitilo; Govinda Aryal; Jessica M Engel
Journal:  Clin Med Res       Date:  2012-06-21

2.  Hereditary diffuse gastric cancer: laparoscopic surgical approach associated to rare mutattion of CDH1 gene.

Authors:  Eurico Cleto Ribeiro de Campos; Saturnino Ribeiro; Rafaella Higashi; Ricardo Manfredini; Diogo Kfouri; Teresa Cristina Santos Cavalcanti
Journal:  Arq Bras Cir Dig       Date:  2015 Apr-Jun

3.  Mutation screen and RNA analysis disclose the changed splicing of the E-cadherin transcription in gastric cancer.

Authors:  Xiaowei Li; Yafan Gao; Yiyuan Pan; Yan Pan; Lifeng Wang; Nong Xiao; Qiong He; Yimei Fan; Yaping Wang
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

Review 4.  Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics.

Authors:  Qiu Peng; Yujuan Zhou; Linda Oyang; Nayiyuan Wu; Yanyan Tang; Min Su; Xia Luo; Ying Wang; Xiaowu Sheng; Jian Ma; Qianjin Liao
Journal:  Mol Ther       Date:  2021-11-15       Impact factor: 11.454

5.  Transcriptome profiling of cancer tissues in Chinese patients with gastric cancer by high-throughput sequencing.

Authors:  Peiying Tian; Chunli Liang
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

Review 6.  Impact of Alternative Splicing Variants on Liver Cancer Biology.

Authors:  Jose J G Marin; Maria Reviejo; Meraris Soto; Elisa Lozano; Maitane Asensio; Sara Ortiz-Rivero; Carmen Berasain; Matias A Avila; Elisa Herraez
Journal:  Cancers (Basel)       Date:  2021-12-21       Impact factor: 6.639

7.  Evaluation of Bioinformatic Programmes for the Analysis of Variants within Splice Site Consensus Regions.

Authors:  Rongying Tang; Debra O Prosser; Donald R Love
Journal:  Adv Bioinformatics       Date:  2016-05-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.